Cargando…
Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming
Platinum drug treatment is one of the most predominant chemotherapeutic strategies for patients with gastric cancer (GC). However, the therapeutic effect is less than satisfactory, largely due to the acquired resistance to platinum drugs. Therefore, a better understanding of the underlying mechanism...
Autores principales: | Dai, Yi, Li, Fan, Jiao, Yuwen, Wang, Guoguang, Zhan, Tian, Xia, Yunwei, Liu, Hanyang, Yang, Haojun, Zhang, Jianping, Tang, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196146/ https://www.ncbi.nlm.nih.gov/pubmed/34117210 http://dx.doi.org/10.1038/s41420-021-00517-w |
Ejemplares similares
-
Involvement and Targeted Intervention of Mortalin-Regulated Proteome Phosphorylated-Modification in Hepatocellular Carcinoma
por: Yang, Ye, et al.
Publicado: (2021) -
Mortalin, Apoptosis, and Neurodegeneration
por: Londono, Carolina, et al.
Publicado: (2012) -
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells
por: Starenki, Dmytro, et al.
Publicado: (2019) -
Mortalin deficiency suppresses fibrosis and induces apoptosis in keloid spheroids
por: Lee, Won Jai, et al.
Publicado: (2017) -
miR-3664-5P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF-κB signaling pathway through targeting MTDH
por: Jiao, Yuwen, et al.
Publicado: (2019)